ORUM THERAPEUTICS ANNOUNCES U.S. FDA CLEARANCE OF AN IND APPLICATION FOR ORM-1153, A NOVEL CD123-GSPT1 DEGRADER-ANTIBODY CONJUGATE

Reuters · 2d ago

Please log in to view news